Answers are grounded in this paper and cite their sources.
In recent years, the application of microfluidic chips in atherosclerosis (AS) research has garnered significant attention. This technology, renowned for its precise control of fluid dynamics at the microscale and its ability to stimulate complex physiological environments, has emerged as a powerful tool for studying AS pathogenesis and conducting drug screening. This study reviews the essential materials for microfluidic chips and their functional characteristics, exploring the application scenarios of various materials in terms of biocompatibility, physicochemical properties, and process adaptability. It focuses on the core technologies and recent advancements in microfluidic chips for stimulating hemodynamics, cell culture, and multicellular interactions, particularly in key pathological processes of AS, such as early lesion formation, thrombosis, and inflammatory responses. Additionally, the article highlights major challenges and future directions for the clinical translation of microfluidic chips, including material innovation and advanced manufacturing techniques for complex structures. These studies provide critical support for understanding AS mechanisms and therapies, while envisioning their potential in personalized medicine.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: